s6y

Nok Therapeutics, Inc.

Ticker
NKTP
CIK
2038166
Industry
Pharmaceutical Preparations

Financials 4

  1. 1-SA Semiannual Report Pursuant to Regulation A for period ending Jun 30, 2026
  2. 1-K Annual Report Pursuant to Regulation A for period ending Dec 31, 2025
  3. 1-SA Semiannual Report Pursuant to Regulation A for period ending Jun 30, 2025
  4. 1-K Annual Report Pursuant to Regulation A for period ending Dec 31, 2024

News 2

  1. 1-U Current Report pursuant to Regulation A
  2. 1-U Current Report pursuant to Regulation A

Prospectus 7

  1. 1-A/A Offering statement under Regulation A
  2. 1-A/A Offering statement under Regulation A
  3. 1-A/A Offering statement under Regulation A
  4. 1-A/A Offering statement under Regulation A
  5. 1-A/A Offering statement under Regulation A
  6. 1-A/A Offering statement under Regulation A
  7. 1-A Offering statement under Regulation A

Other 21

  1. D/A Exempt (Private) Offering
  2. D/A Exempt (Private) Offering
  3. D/A Exempt (Private) Offering
  4. D/A Exempt (Private) Offering
  5. D/A Exempt (Private) Offering
  6. D Exempt (Private) Offering
  7. D Exempt (Private) Offering
  8. D Exempt (Private) Offering
  9. QUALIF
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 21 other filings